SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is drawing heavy investor attention as the market anticipates a catalyst-heavy year, featuring three critical Phase 3 data readouts for its lead psychiatry program. While some community members voice concerns over potential share dilution and historical management turnover, bullish sentiment remains centered on the company's strong cash position and the regulatory potential for its novel LSD-based therapy in a massive total addressable market.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku shares are surging following a Bloomberg report that the company is exploring strategic options, including a potential sale to a major media firm. The news has ignited significant community debate, with traders analyzing the stock's newfound momentum, the viability of various buyout candidates, and the potential for a larger breakout as institutional interest grows.

Tidal Trust II - YieldMax Ultra Option Income Strategy ETF

YieldMax Ultra Option Income Strategy ETF

ULTY is trending as investors digest the impact of a 1-for-10 reverse stock split and a strategic shift toward lower-volatility, large-cap holdings intended to stabilize net asset value. Community sentiment remains polarized, with debates centering on whether the revamped portfolio and ongoing weekly distributions can counteract persistent NAV decay versus the risks of further share price erosion.

WorldFinancial

WLFI is trending as investors debate whether the token is a legitimate DeFi opportunity or a high-risk scam amid ongoing lawsuits, governance votes, and significant price volatility. The community remains deeply polarized, with some bulls pointing to supply scarcity and potential token burns as catalysts for a recovery, while others emphasize the lack of utility and negative sentiment surrounding its association with high-profile figures.

Blue Owl Capital, Inc. operates as an alternative asset management firm. It provides investors access to asset management capital solutions through its Direct Lending and GP Capital Solutions products. The company offers a platform of capital solutions to both middle market companies and large alternative asset managers. The company was founded by Doug Irving Ostrover, Michael Rees and Craig W.Packer in 2009 and is headquartered in New York, NY.

Blue Owl Capital Inc - Ordinary Shares - Class A

Blue Owl is currently trending due to intensifying scrutiny of the private credit sector, characterized by rising redemption requests and concerns regarding loan quality. Community discussions reflect a polarized sentiment, with some investors leveraging the price weakness as a deep-value opportunity while others warn of broader liquidity risks and potential systemic exposure to the software industry.

The GEO Group, Inc. engages in the design, financing, development, and support services for secure facilities, processing centers, and community re-entry facilities. It operates through the following segments: U.S. Secure, Electronic Monitoring and Supervision, Reentry, and International Services. The U.S. Secure Services segment encompasses the United States-based public-private partnership corrections and detention business. The Electronic Monitoring and Supervision Services segment conducts its services in the U.S. The Reentry Services Segment consists of various community-based and reentry services. The International Services segment consists of public-private partnership secure services operations in Australia and South Africa. The company was founded by George C. Zoley in 1984 and is headquartered in Boca Raton, FL.

Geo Group, Inc.

Geo Group is experiencing significant momentum driven by government-backed ICE funding and the strategic expansion of detention capacity, with the community actively discussing a potential short squeeze fueled by high institutional ownership and speculative long-dated call options. Investors are closely tracking the company's role in federal immigration enforcement and the potential for asset sales or a government-led acquisition to unlock value.

Zillow Group, Inc. engages in the provision of real estate and home-related information marketplaces on mobile and the web. The company was founded by Richard N. Barton and Lloyd D. Frink in December 2004 and is headquartered in Seattle, WA.

Zillow Group Inc - Ordinary Shares - Class C

Zillow Group Inc Class C

Zillow is facing significant downward pressure as investors react to an antitrust lawsuit filed by the FTC and several states over allegations of anti-competitive practices in rental advertising. The community is actively debating the stock's future, with many weighing the impact of legal risks against Zillow's strategic integration of AI and its position as a dominant, profitable leader in the housing market.

Chip

Chip is trending as investors debate its role as a GPU-backed lending protocol amid significant price volatility and ongoing arguments between those betting on its AI infrastructure utility and others calling it a pump-and-dump scheme. The community is actively tracking its protocol fees and loan pipeline while speculating on whether recent price action represents a bear trap or a continued downward trend.

Oatly Group AB is a holding company, which focuses on developing expertise around oats, a global power crop with inherent properties suited for sustainability and human health. It operates through the following geographical segments: Europe & International, North America and Greater China. The company was founded by Björn Öste in 1994 and is headquartered in Malmö, Sweden.

Oatly Group AB - ADR

Oatly Group

Investors are closely monitoring Oatly due to rumors of a potential China carve-out deal, which community members believe could significantly improve the balance sheet and unlock value. Despite frustration over stagnant price action, the discussion remains focused on optimistic long-term growth prospects, strong brand positioning, and the anticipation of upcoming quarterly results.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is trending as the market digests strong trading updates and continued progress on strategic nuclear projects like SMRs, even as investors navigate ongoing volatility from geopolitical tensions in the Middle East. The community is focused on the company's resilient profit outlook and major defense-related contract wins, which are being weighed against broader concerns about fuel costs and global travel demand.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biotech Surges as Big Money Backs High-Stakes Kidney Disease Push

The immune system has become one of biotech's most important battlegrounds as drug developers race to target inflammatory pathways responsible for some of medicine's most difficult-to-treat diseases. Among the most closely watched areas is the complement system, a network of proteins that can trigger severe tissue damage when overactivated. With growing interest in kidney disorders and autoimmune diseases, investors are increasingly rewarding companies developing targeted therapies capable of interrupting these pathways with greater precision and fewer side effects.Shares of InflaRx N.V. ...

InflaRx N.V. (NASDAQ:IFRX) Short Interest Update

InflaRx N.V. (NASDAQ:IFRX - Get Free Report) was the recipient of a large decline in short interest in April. As of April 15th, there was short interest totaling 1,809,027 shares, a decline of 26.2% from the March 31st total of 2,452,174 shares. Approximately 3.0% of the company's stock are short...

InflaRx (IFRX) Expected to Announce Quarterly Earnings on Wednesday

InflaRx (NASDAQ:IFRX) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-6-inflarx-stock...

InflaRx (NASDAQ:IFRX) Coverage Initiated at Oppenheimer

Oppenheimer initiated coverage on InflaRx in a report on Friday. They set an "outperform" rating and a $5.00 price target on the stock...

InflaRx's (IFRX) "Buy" Rating Reaffirmed at Guggenheim

Guggenheim reiterated a "buy" rating and set a $14.00 price target on shares of InflaRx in a report on Tuesday...

InflaRx N.V. (NASDAQ:IFRX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

InflaRx N.V. (NASDAQ:IFRX - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the seven analysts that are covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, one has issued a hold rating and five have issued a buy ratin...

InflaRx (NASDAQ:IFRX) Stock Price Up 32.5% - Should You Buy?

InflaRx (NASDAQ:IFRX) Stock Price Up 32.5% - Still a Buy...

InflaRx N.V. (NASDAQ:IFRX) Given Consensus Rating of "Moderate Buy" by Brokerages

Shares of InflaRx N.V. (NASDAQ:IFRX - Get Free Report) have received a consensus rating of "Moderate Buy" from the seven brokerages that are covering the stock, Marketbeat Ratings reports. One...

HC Wainwright Forecasts InflaRx's Q3 Earnings (NASDAQ:IFRX)

InflaRx N.V. (NASDAQ:IFRX - Free Report) - Analysts at HC Wainwright issued their Q3 2026 EPS estimates for InflaRx in a research note issued on Thursday, March 19th. HC Wainwright analyst M. Keller...

InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab. The company was founded by Niels Christoph Riedemann, Renfeng Guo, and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.07	--	--	N/A
Q1 '26	-$0.14	--	--	N/A
Q4 '25	-$0.16	--	--	N/A
Q3 '25	-$0.21	--	--	N/A
Q2 '25	-$0.22	-$0.24	-13.19%	MISSED

IFRXInflaRx N.V.

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '26

Historical Earnings

Latest IFRX News